Tyler Technologies
TYL
$322.31
+0.46%
Tyler Technologies, Inc. is a leading provider of integrated software and technology services specifically designed for the public sector, including cities, counties, schools, and courts. The company is a dominant market leader in the niche of government software, with a comprehensive suite anchored by its Munis ERP, Odyssey court management, and payments platforms. The current investor narrative is dominated by a significant stock price correction and concerns over execution, as recent financial results and guidance appear to have disappointed the market, leading to a sharp reassessment of its growth trajectory and valuation premium.…
TYL
Tyler Technologies
$322.31
Investment Opinion: Should I buy TYL Today?
Rating: Hold. The core thesis is that while the stock appears oversold after a 43% decline and enjoys strong analyst support, the fundamental deterioration in growth and margins is too severe to warrant a Buy rating until evidence of stabilization emerges.
Supporting evidence includes the stock's valuation reset to a forward P/E of 22.4x, which is more reasonable than its trailing 62x multiple, and implies the market expects an earnings recovery. Analyst consensus expects EPS of $16.29 on revenue of $3.02B, indicating expectations for resumed growth. The company's robust TTM free cash flow of $637.5M and healthy balance sheet (D/E 0.18) provide a financial safety net. However, the sharp Q4 margin compression (gross margin down 410 bps sequentially) and slowing revenue growth (6.3% YoY) are clear red flags that offset these positives.
The thesis would upgrade to Buy if the company demonstrates gross margin stabilization above 44% and revenue growth re-accelerates above 8% YoY in the next quarter, confirming the issues are temporary. It would downgrade to Sell if margins continue to compress below 40% and revenue growth falls below 5%, signaling a structural problem. Currently, the stock is fairly valued relative to its diminished near-term growth prospects but remains overvalued if the recent profitability compression proves permanent.
Sign up to view all
TYL 12-Month Price Forecast
The investment stance is neutral, reflecting a battle between a deeply oversold technical picture with strong institutional support and concerning fundamental deterioration. The forward P/E of 22.4x prices in a recovery that is not yet evident in the reported numbers. Confidence is medium due to the high uncertainty around whether margin compression is cyclical or structural. The stance would upgrade to bullish on evidence of sequential margin improvement and stabilization of revenue growth above 7%. It would turn bearish if the next quarter shows further margin erosion and growth falling below 5%, confirming a negative trend.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Tyler Technologies's 12-month outlook, with a consensus price target around $419.00 and implied upside of +30.0% versus the current price.
Average Target
$419.00
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$258 - $419
Analyst target range
The stock is covered by at least 7 analysts, as evidenced by the EPS estimates provided, and institutional rating actions show a pattern of reiterated bullish stances following the recent decline. The consensus sentiment leans bullish, with recent actions from firms like DA Davidson (upgrading to Buy), Stifel (Buy), TD Cowen (Buy), Barclays (Overweight), Needham (Buy), Oppenheimer (Outperform), and Piper Sandler (Overweight) indicating strong institutional support. The average revenue estimate for the next period is approximately $3.02 billion, with a tight range between $3.02B and $3.03B, suggesting high conviction on the top-line outlook. The average EPS estimate is $16.29, with a narrow range from $16.12 to $16.45, further indicating analyst consensus. The wide dispersion in recent stock price targets is not provided in the data, but the clustering of bullish ratings immediately after a sharp price drop suggests analysts view the sell-off as overdone, providing a potential floor for the stock.
Bulls vs Bears: TYL Investment Factors
The evidence is currently balanced but tilts bearish in the near term due to the severity and persistence of the fundamental deterioration. The bull case rests on the stock's oversold condition, strong analyst support, and solid financial foundation, while the bear case is driven by concrete evidence of slowing growth and collapsing margins. The single most important tension in the investment debate is whether the Q4 margin compression and growth deceleration represent a temporary execution stumble or the beginning of a sustained downcycle for this former growth leader. The resolution of this issue, as seen in upcoming quarterly reports, will determine if the stock is a deep-value turnaround or a value trap.
Bullish
- Strong Analyst Support: Despite a 43% price drop, multiple major firms have reiterated or upgraded to Buy/Overweight ratings, including DA Davidson, Stifel, and Barclays. This concentrated institutional support suggests the sell-off is viewed as overdone and provides a potential valuation floor.
- Robust Cash Generation: The company generates substantial free cash flow, with TTM FCF of $637.5 million. This strong cash flow provides significant financial flexibility to navigate growth challenges, invest in the business, and potentially pursue share buybacks.
- Healthy Balance Sheet: A low debt-to-equity ratio of 0.18 and a current ratio of 1.05 indicate a conservative capital structure and ample liquidity. This financial strength reduces bankruptcy risk and provides a buffer against operational headwinds.
- Valuation Reset to Historical Lows: The stock's trailing PS ratio of 8.39x and forward P/E of 22.4x are near the lower end of its multi-year historical range. This suggests the market has priced in a severe growth deceleration, leaving room for multiple expansion if execution stabilizes.
Bearish
- Severe Growth Deceleration: Q4 2025 revenue growth slowed to 6.3% YoY, a sharp deceleration from prior quarters. Revenue also declined sequentially from ~$596M in Q2/Q3 to $575M in Q4, signaling potential demand headwinds or a lumpy sales cycle.
- Sharp Profitability Compression: Gross margin fell to 43.1% in Q4 from 47.2% in Q3, and net margin compressed to 11.4% from 14.2%. This indicates significant pricing pressure, cost inflation, or an unfavorable revenue mix, directly impacting earnings power.
- Extreme Technical Downtrend: The stock is down 43% over the past year and 29% over the past three months, trading just 10% above its 52-week low. This persistent selling pressure indicates a fundamental re-rating is underway, with no clear technical bottom yet established.
- High Trailing Valuation: Despite the crash, the trailing P/E remains elevated at 61.99x, reflecting compressed earnings. This high multiple leaves the stock vulnerable to further downside if forward earnings estimates of $16.29 are revised lower.
TYL Technical Analysis
The stock is in a pronounced and severe downtrend, having declined 43.09% over the past year. With a current price of $317.30, it is trading near the lower end of its 52-week range of $283.72 to $621.34, positioning it at approximately 10% above the 52-week low. This deep decline suggests the stock is being priced for significant distress or a major growth reset, presenting a potential value opportunity but also carrying substantial 'falling knife' risk. Recent momentum shows no signs of a durable reversal, with the stock down 8.91% over the past month and 29.23% over the past three months, indicating that selling pressure remains intense and the longer-term downtrend is accelerating. The stock's beta of 0.921 indicates it has been slightly less volatile than the broader market during this period, which is unusual for a high-growth software name experiencing such a sharp correction. Key technical support is clearly defined at the 52-week low of $283.72, while resistance has been established at the recent breakdown level around $350-370. A breakdown below $283.72 would signal a new leg down, whereas a sustained move above the $370 resistance zone would be the first technical evidence of a potential bottoming process.
Beta
0.92
0.92x market volatility
Max Drawdown
-53.1%
Largest decline past year
52-Week Range
$284-$621
Price range past year
Annual Return
-43.6%
Cumulative gain past year
| Period | TYL Return | S&P 500 |
|---|---|---|
| 1m | -7.9% | +4.9% |
| 3m | -28.7% | +0.6% |
| 6m | -35.1% | +5.1% |
| 1y | -43.6% | +28.8% |
| ytd | -26.0% | +1.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
TYL Fundamental Analysis
Revenue growth has decelerated significantly, with Q4 2025 revenue of $575.2 million representing a year-over-year increase of 6.3%, a notable slowdown from the higher growth rates seen in prior quarters of 2025. The quarterly trend shows revenue peaked in Q2 and Q3 2025 at approximately $596 million before dipping in Q4, suggesting potential demand headwinds or a lumpy sales cycle. The company remains profitable, with Q4 2025 net income of $65.5 million and a net margin of 11.4%, but profitability has compressed from the stronger levels seen earlier in the year, such as the 14.2% net margin in Q3. Gross margin for Q4 was 43.1%, down from 47.2% in Q3, indicating potential pricing pressure or a less favorable revenue mix. The balance sheet is healthy with a low debt-to-equity ratio of 0.18, and the company generates substantial cash, evidenced by trailing twelve-month free cash flow of $637.5 million. This strong cash generation, coupled with a current ratio of 1.05, provides financial flexibility to navigate the current challenges, though the return on equity of 8.5% reflects diminished profitability on shareholder capital.
Quarterly Revenue
$575179000.0B
2025-12
Revenue YoY Growth
+0.06%
YoY Comparison
Gross Margin
+0.43%
Latest Quarter
Free Cash Flow
$637528000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is TYL Overvalued?
Given the company's positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is exceptionally high at 61.99x, while the forward P/E is a more reasonable 22.36x. This massive gap implies the market expects a significant recovery in earnings over the next year, pricing in the recent profit compression as a temporary issue. Compared to the provided industry average data, the stock's trailing P/E of 61.99x and PS ratio of 8.39x are not directly comparable without sector benchmarks, but the forward P/E of 22.4x suggests a premium growth expectation. Historically, the stock's own valuation has contracted dramatically from its recent peaks; for instance, its trailing P/E at the end of Q3 2025 was 66.73x and its PS ratio was 37.8x. The current PS ratio of 8.39x and forward P/E of 22.4x place it near the lower end of its own multi-year historical range, suggesting the market has already priced in a significant deterioration in growth prospects, leaving room for multiple expansion if execution stabilizes.
PE
62.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 67x~181x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
38.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on the company's deteriorating profitability profile. The sequential gross margin decline from 47.2% to 43.1% and net margin drop from 14.2% to 11.4% in the latest quarter indicate significant pressure that, if sustained, would severely impair earnings growth. Revenue growth decelerating to 6.3% YoY raises concerns about the sustainability of its premium valuation, which is still high at a 61.99x trailing P/E. While the balance sheet is strong (D/E 0.18), the company's return on equity of 8.5% reflects diminished profitability on shareholder capital.
Market & Competitive Risks are elevated due to the stock's massive valuation compression and loss of growth narrative. Trading at a forward P/E of 22.4x, it still carries a growth premium that is vulnerable if revenue growth remains in the mid-single digits. The stock's beta of 0.92 suggests it has been slightly less volatile than the market during its crash, but this atypical behavior for a software stock may indicate continued institutional selling. The primary risk is further multiple contraction if the market reclassifies TYL from a growth stock to a value stock, which could compress the forward P/E toward industry averages for mature software companies.
The Worst-Case Scenario involves a continuation of the current negative momentum: Q1 2026 results show further margin erosion and growth deceleration below 5%, triggering analyst downgrades and estimate cuts. This could break technical support at the 52-week low of $283.72, leading to a capitulation sell-off. In this adverse scenario, the stock could realistically test the $250 level, representing a further -21% downside from the current price of $317.30. The maximum drawdown from the 52-week high is already -54%, highlighting the catastrophic damage that has already occurred to long-term holders.
FAQ
The key risks are, in order of severity: 1) Operational Risk: Continued erosion of gross margins (down 410 bps sequentially) and further deceleration of revenue growth below 6.3%. 2) Valuation Risk: The forward P/E of 22.4x could compress further if growth slows more, as the stock may be re-rated as a value stock. 3) Sentiment Risk: The stock has dramatically underperformed the market (-72.6% relative strength), and a loss of analyst confidence could remove a key support. 4) Market Risk: Although its government focus is defensive, a deep recession could still pressure state and local IT budgets.
The 12-month forecast is bifurcated, with a base case target range of $340-$380 (55% probability), a bull case of $400-$450 (25%), and a bear case of $250-$283 (20%). The base case, which is most likely, assumes the company meets analyst consensus for ~$3.02B in revenue and $16.29 in EPS, with margins stabilizing at current levels. This scenario implies modest upside from the current price. The forecast hinges almost entirely on whether the company can halt the margin compression and growth deceleration seen in Q4 2025.
TYL's valuation is in a state of transition and is fairly valued based on its near-term prospects. The trailing P/E of 62x is misleadingly high due to compressed earnings, but the forward P/E of 22.4x is more indicative, pricing in a significant earnings recovery. Compared to its own historical multiples, the PS ratio of 8.39x is near multi-year lows, suggesting the market has already priced in a growth reset. The valuation implies the market expects the company to deliver on analyst EPS estimates of $16.29, which requires margin stabilization. It is not clearly undervalued until growth stabilizes.
TYL presents a high-risk, potentially high-reward opportunity but is not a clear-cut good buy at this moment. For aggressive investors comfortable with turnaround situations, the 43% decline and strong analyst support (multiple recent Buy ratings) could signal a bottom. However, the severe growth deceleration to 6.3% and sharp margin compression are major red flags. It could be a good buy for patient, long-term investors if they believe the company's dominant market position will allow it to stabilize and eventually re-accelerate growth, but it carries significant risk of further downside if the operational deterioration continues.
TYL is unsuitable for short-term trading due to its high volatility and lack of near-term positive catalysts; it is a classic 'falling knife.' It is only suitable for long-term investors with a minimum 2-3 year horizon who can weather further volatility. The investment thesis is a long-term turnaround story based on the company's entrenched market position and strong cash flow generation. The low beta of 0.92 is deceptive given the stock's 43% annual decline, and the lack of a dividend means total return is solely dependent on price appreciation, which requires patience.